US FDA Cancer Reviewers Heading For The Exits, Potentially Impacting Review Timelines

 
• By Sarah Karlin-Smith
  
People in business clothes with brief cases on conveyer belt, heading towards an exit door.
The Trump transition is causing many FDA cancer reviewers to seek employment elsewhere. (Shutterstock)

More from US FDA

More from Agency Leadership